Page last updated: 2024-08-23

raloxifene hydrochloride and zoledronic acid

raloxifene hydrochloride has been researched along with zoledronic acid in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	12 (85.71)	24.3611
2020's	2 (14.29)	2.80

Authors

Authors	Studies
Bauer, DC; Schousboe, JT	1
Suzuki, H; Takeuchi, Y	1
Baker, SP; Boskey, AL; Brooks, DJ; Burket, JC; MacLeay, JM; van der Meulen, MC	1
Gandhi, S; Modi, A; Sen, S; Siris, ES; Tang, J	1
Diab, DL; Watts, NB	1
Bouvet, A; Caruba, T; Pouchot, J; Sabatier, B; Savoldelli, V	1
Reid, IR	1
Barron, R; Durden, E; Juneau, P; Lopez-Gonzalez, L; Pinto, L	1
Allen, MR; Aref, MW; Brown, D; Gupta, A; McNerny, EMB; Meixner, CN; Wallace, JM	1
Allen, MR; Alvarez, MB; Bidwell, JP; Burr, DB; Childress, P; Condon, KW; Davis, H; He, Y; Hernandez-Buquer, S; Plotkin, LI; Robling, AG; Shao, Y; Stayrook, KR; Warden, SJ; Wek, RC; Yang, FC	1
Balasubramanian, A; Cooper, C; Cummings, SR; Feudjo, MT; Guo, H; Sprafka, JM; Watts, NB; Yusuf, AA; Zhou, J	1
Allen, MR; Berman, A; Powell, KM; Pulliam, A; Skaggs, C; Wallace, JM	1
Baim, S; Bedrose, S; Casagrande, A; Go, MT; Goel, M; Hanna, M; Husni, H; Li, D; Mahrous, P; Morkos, M	1
Chen, CH; Chen, WJ; Chen, YM; Chien, LN; Ku, CK; Li, CY; Lin, SY	1

Reviews

3 review(s) available for raloxifene hydrochloride and zoledronic acid

Article	Year
Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy. Current osteoporosis reports, 2012, Volume: 10, Issue:1 Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Humans; Imidazoles; Monitoring, Physiologic; Osteoporotic Fractures; Raloxifene Hydrochloride; Wound Healing; Zoledronic Acid	2012
[Combination or sequential treatment using PTH and anti-resorption therapies]. Clinical calcium, 2012, Volume: 22, Issue:3 Topics: Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Teriparatide; Time Factors; Zoledronic Acid	2012
Postmenopausal osteoporosis. Current opinion in endocrinology, diabetes, and obesity, 2013, Volume: 20, Issue:6 Topics: Accidental Falls; Aged; Alendronate; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium; Denosumab; Dietary Supplements; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Risk Reduction Behavior; Teriparatide; Vitamin D; Zoledronic Acid	2013

Other Studies

11 other study(ies) available for raloxifene hydrochloride and zoledronic acid

Article	Year
Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment. Bone, 2013, Volume: 52, Issue:1 Topics: Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Imidazoles; Nanotechnology; Osteoporosis; Raloxifene Hydrochloride; Sheep; Spectrum Analysis, Raman; Zoledronic Acid	2013
Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis. Current medical research and opinion, 2014, Volume: 30, Issue:1 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Calcitonin; Cohort Studies; Diphosphonates; Etidronic Acid; Female; Humans; Ibandronic Acid; Imidazoles; Managed Care Programs; Middle Aged; Osteoporosis; Raloxifene Hydrochloride; Retrospective Studies; Risedronic Acid; Teriparatide; United States; Zoledronic Acid	2014
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; France; Hip Fractures; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Prescriptions; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D; Wrist Injuries; Zoledronic Acid	2014
Efficacy, effectiveness and side effects of medications used to prevent fractures. Journal of internal medicine, 2015, Volume: 277, Issue:6 Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid	2015
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States. Archives of osteoporosis, 2017, Volume: 12, Issue:1 Topics: Aged; Bone Density Conservation Agents; Denosumab; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Logistic Models; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; Postmenopause; Raloxifene Hydrochloride; Retrospective Studies; Risedronic Acid; United States; Zoledronic Acid	2017
Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate. Calcified tissue international, 2017, Volume: 101, Issue:1 Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Femur; Imidazoles; Male; Mice; Mice, Inbred C57BL; Raloxifene Hydrochloride; Zoledronic Acid	2017
Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism. Endocrinology, 2017, 09-01, Volume: 158, Issue:9 Topics: Animals; Bone and Bones; Bone Resorption; Diphosphonates; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Imidazoles; Mice; Mice, Knockout; Nuclear Matrix-Associated Proteins; Osteoporosis; Parathyroid Hormone; Raloxifene Hydrochloride; Transcription Factors; Zoledronic Acid	2017
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women. Archives of osteoporosis, 2018, Mar-21, Volume: 13, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Denosumab; Female; Humans; Incidence; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Raloxifene Hydrochloride; Spinal Fractures; Teriparatide; United States; Zoledronic Acid	2018
Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone. Bone, 2019, Volume: 127 Topics: Animals; Biomechanical Phenomena; Bone Diseases; Calcification, Physiologic; Cancellous Bone; Diaphyses; Drug Therapy, Combination; Femur; Fractures, Bone; Male; Mice, Inbred C57BL; Raloxifene Hydrochloride; Zoledronic Acid	2019
Patterns of Osteoporosis Medications Selection After Drug Holiday or Continued Therapy: A Real-World Experience. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2022, Volume: 28, Issue:10 Topics: Aged; Alendronate; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Ibandronic Acid; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; United States; Zoledronic Acid	2022
Treatment patterns of long-dose-interval medication for persistent management of osteoporosis in Taiwan. Archives of osteoporosis, 2022, 07-15, Volume: 17, Issue:1 Topics: Aged; Alendronate; Bone Density Conservation Agents; Denosumab; Female; Humans; Ibandronic Acid; Male; Medication Adherence; Osteoporosis; Raloxifene Hydrochloride; Retrospective Studies; Taiwan; Teriparatide; Zoledronic Acid	2022